谁将获得首款获批的 psychedelic 药物?
STAT+: Who will get the first psychedelic approved?
Compass Pathways 被视为首款 psychedelic 药物获批的领跑者,但非营利组织也在紧追不舍。两家公司均在积极推进相关研发。
Gilead’s HIV prevention shot goes generic, Bright Minds’ seizure drug on hold, and more biotech news
![]()
Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70.
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Good morning. The midterms are here. My colleagues will be closely tracking the elections and their implications on health policy, so check back in for our coverage. We also have a helpful primer here.
The need-to-know this morning
- Pfizer earnings. Madrigal Pharma earnings. Alkermes earnings. BioNTech earnings.
- Vertex Pharma reported earnings on Monday night, as did Neurocrine Biosciences.
Who will get the first psychedelic approved?
The biotech Compass Pathways has been seen as one of the frontrunners in the race to get the first psychedelic drug approved. But it could be a tight race, with a non-profit organization closing in on its own efforts.
STAT+ Exclusive Story
Already have an account? Log in

This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
Already have an account? Log in
To read the rest of this story subscribe to STAT+.
-
National Biotech Reporter
Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70.
来源:STAT 主站 · statnews.com